If its a prescription medication prescribed to treat a qualifying medical condition, it should be eligible
Ive observed that there are 5 obstacles patients experience with these medications as treatments for obesity and diabetes: Cost of the meds Side effects and tolerability Fear of needles Concerns about safety The moral failing of needing a medication Oral GLP1 drugs like orforglipron (Foundayo) and Wegovy work almost as well as the injectable version of these drugs The FDA just approved oral Foundayo for the treatment of obesity based on the results of the ATTAIN-1 trial, recently published in NEJM
Starting early means your skin is actively tightening Collagen production takes time
Common and Severe Side Effects of Compounded Tirzepatide Like any medication, side effects of Tirzepatide should be carefully considered
Additionally, the cost and accessibility of Semaglutide, especially given its current use for diabetes and obesity, may pose barriers to its widespread adoption for IBS treatment
Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury